
AI Is Not Ready to Be the Decision-Maker — And Pretending Otherwise Is the Real Risk
This article warns biopharma leaders against mistaking rapid, cleanly formatted AI outputs for trustworthy decision-making tools, emphasizing that while AI excels at compressing analysis time and supporting directional scenario planning, treating it as an authoritative decision-maker introduces hidden risks and masks underlying process weaknesses.





